TRIPS

5 articles available

Looking at the pharmaceutical law reform package prepared by the European Commission it is clear that, quite sadly, incentivizing inventions and innovation in the pharmaceutical industry no longer…

(UPDATED) The US has thrown its support behind an initiative at the World Trade Organization (WTO) to temporarily waive intellectual property rights in response to the Covid-19 pandemic. Late April…

When a company is not prepared to charge a socially acceptable price in the Netherlands for a medicine, the government should use other instruments such as compulsory licences, encouraging pharmacy…

Probir J Mehta (Acting Assistant US Trade Representative for IP and Innovation) refers to IP being a critical part of the trade agenda and America's future. The trans-pacific partnership is a…

One of the topics most hotly discussed before the Spanish Courts over the last few years is whether the legal effects of the TRIPS' provisions on patents are governed by Community law or by the…